Capmatinib hydrochloride
Capmatinib hydrochloride is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR) with potential antineoplastic activity.Capmatinib was found to be highly selective for MET over other kinases. It was active against cancer models that are characterized by MET amplification, marked MET overexpression, MET exon 14 skipping mutations, or MET activation via expression of the ligand hepatocyte growth factor (HGF) .
Product Specifications
CAS Number
1865733-40-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
503.4
Molecular Formula
C23H21Cl2FN6O2
Notes
Research use only, not for human use.
Receptor
C-Met
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6490304 1.0 µg DNA
RGD1563667 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
RPC20422-01 20 µg
Recombinant Arabidopsis thaliana Osmotin-like protein OSM34 (OSM34)
Sign In for Pricing
View Details RPC20422-02 100 µg
Recombinant Arabidopsis thaliana Osmotin-like protein OSM34 (OSM34)
Sign In for Pricing
View Details RPC20422-03 1 mg
Recombinant Arabidopsis thaliana Osmotin-like protein OSM34 (OSM34)
Sign In for Pricing
View Details